During the past decade, Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Intercept Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are "Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Crohn Disease" (2 trials), "Chronic Hepatitis C Infection" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" in a lesser frequency.

Most popular intervention types in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are "Drug" (14 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrolizumab" (4 trials), "Mirikizumab" (2 trials), "Asacol" (1 trials) and "Copegus®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".